abstract |
Disclosed are novel chemical conjugates of psychotropic drugs and organic acids and their use in the treatment of CNS and / or proliferative disorders and diseases. The organic acid is selected to reduce the side effects induced by the psychotropic drug, to enhance the therapeutic activity of the psychotropic drug, and / or to exert anti-proliferative activity. [Selection figure] None |